Publication:
Venetoclax-rituximab in chronic lymphocytic leukemia

Simple item page
dc.contributor.coauthorÖzbalak, Murat
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.kuauthorÖztürk, Erman
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofileDoctor
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.unitKoç University Hospital
dc.contributor.yokid18320
dc.date.accessioned2024-11-09T23:50:45Z
dc.date.issued2018
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue22
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume378
dc.identifier.doi10.1056/NEJMc1805135
dc.identifier.eissn1533-4406
dc.identifier.issn0028-4793
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85047763925
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14577
dc.identifier.wos433428000020
dc.keywordsOpen label
dc.keywordsBendamustine
dc.keywordsMulticenter
dc.languageEnglish
dc.publisherMassachusetts Medical Society (MMS)
dc.sourceNew England Journal of Medicine
dc.subjectMedicine
dc.subjectGeneral
dc.subjectInternal
dc.titleVenetoclax-rituximab in chronic lymphocytic leukemia
dc.typeLetter
dspace.entity.typePublication
local.contributor.authorid0000-0002-4257-549X
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan
local.contributor.kuauthorÖztürk, Erman

Files

Collections

Publications without Fulltext